Article
Targeting the Wnt Pathway in Synovial Sarcoma Models
6 Aug 2013
Abstract excerpt
UNLABELLED: Synovial sarcoma is an aggressive soft-tissue malignancy of children and young adults, with no effective systemic therapies. Its specific oncogene, SYT-SSX (SS18-SSX), drives sarcoma initiation and development. The exact mechanism of SYT-SSX oncogenic function remains unknown. In an SYT-SSX2 transgenic model, we show that a constitutive Wnt/β-catenin signal is aberrantly activated by SYT-SSX2, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
